| 1 | The growing use of herbal medicines: issues relating to adve… (10.3389/fphar.2013.00177) | Abstract References ORCID License | 338.86 | 2446 |
| 2 | Determinants of patient adherence: a review of systematic re… (10.3389/fphar.2013.00091) | Abstract References ORCID License | 278.32 | 606 |
| 3 | Mechanisms and insights into drug resistance in cancer (10.3389/fphar.2013.00028) | Abstract References ORCID License | 273.72 | 545 |
| 4 | Barrier Mechanisms in the Developing Brain (10.3389/fphar.2012.00046) | Abstract References ORCID License | 262.63 | 422 |
| 5 | Heme Oxygenase-1, Oxidation, Inflammation, and Atheroscleros… (10.3389/fphar.2012.00119) | Abstract References ORCID License | 257.98 | 379 |
| 6 | Resveratrol: French Paradox Revisited (10.3389/fphar.2012.00141) | Abstract References ORCID License | 257.05 | 371 |
| 7 | Therapeutic Potential of Moringa oleifera Leaves in Chronic… (10.3389/fphar.2012.00024) | Abstract References ORCID License | 256.35 | 365 |
| 8 | Aldose Reductase, Oxidative Stress, and Diabetic Mellitus (10.3389/fphar.2012.00087) | Abstract References ORCID License | 255.51 | 358 |
| 9 | Anticancer Targets in the Glycolytic Metabolism of Tumors: A… (10.3389/fphar.2011.00049) | Abstract References ORCID License | 253.15 | 339 |
| 10 | The Ketogenic Diet as a Treatment Paradigm for Diverse Neuro… (10.3389/fphar.2012.00059) | Abstract References ORCID License | 252.37 | 333 |
| 11 | Advances and Challenges of Liposome Assisted Drug Delivery (10.3389/fphar.2015.00286) | Abstract ORCID License | 252.21 | 2305 |
| 12 | Anti-Inflammatory and Immunomodulatory Effects of Paeonia La… (10.3389/fphar.2011.00010) | Abstract References ORCID License | 245.79 | 286 |
| 13 | Microglia Function in Alzheimer’s Disease (10.3389/fphar.2012.00014) | Abstract References ORCID License | 244.72 | 279 |
| 14 | Ginsenosides as anticancer agents: In vitro and in vivo acti… (10.3389/fphar.2012.00025) | Abstract References ORCID License | 244.56 | 278 |
| 15 | Na+ Channel ? Subunits: Overachievers of the Ion Channel Fam… (10.3389/fphar.2011.00053) | Abstract References ORCID License | 243.78 | 273 |
| 16 | The role of cholesterol metabolism and cholesterol transport… (10.3389/fphar.2013.00119) | Abstract References ORCID License | 240.65 | 254 |
| 17 | Neurotoxins and Their Binding Areas on Voltage-Gated Sodium… (10.3389/fphar.2011.00071) | Abstract References ORCID License | 239.79 | 249 |
| 18 | The Role of Bilirubin in Diabetes, Metabolic Syndrome, and C… (10.3389/fphar.2012.00055) | Abstract References ORCID License | 239.09 | 245 |
| 19 | PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Im… (10.3389/fphar.2017.00561) | Abstract ORCID License | 238.47 | 1511 |
| 20 | Bacterial Carbonic Anhydrases as Drug Targets: Toward Novel… (10.3389/fphar.2011.00034) | Abstract References ORCID License | 238.38 | 241 |
| 21 | Astrocytes as a Source for Extracellular Matrix Molecules an… (10.3389/fphar.2012.00120) | Abstract References ORCID License | 237.66 | 237 |
| 22 | Antidepressant effects of ketamine: mechanisms underlying fa… (10.3389/fphar.2013.00161) | Abstract References ORCID License | 236.17 | 229 |
| 23 | Physiology and Pathology of Calcium Signaling in the Brain (10.3389/fphar.2012.00061) | Abstract References ORCID License | 233.24 | 214 |
| 24 | CaMKII inhibitors: from research tools to therapeutic agents (10.3389/fphar.2014.00021) | Abstract References ORCID License | 233.24 | 214 |
| 25 | Cameroonian Medicinal Plants: Pharmacology and Derived Natur… (10.3389/fphar.2010.00123) | Abstract References ORCID License | 232.22 | 209 |
| 26 | Altered Calcium Signaling Following Traumatic Brain Injury (10.3389/fphar.2012.00060) | Abstract References ORCID License | 232.01 | 208 |
| 27 | Pathobiology of cancer chemotherapy-induced peripheral neuro… (10.3389/fphar.2013.00156) | Abstract References ORCID License | 232.01 | 208 |
| 28 | An Overview of the Evidence and Mechanisms of Herb–Drug Inte… (10.3389/fphar.2012.00069) | Abstract References ORCID License | 230.96 | 203 |
| 29 | The epithelium in idiopathic pulmonary fibrosis: breaking th… (10.3389/fphar.2013.00173) | Abstract References ORCID License | 230.75 | 202 |
| 30 | Connexin and pannexin hemichannels in brain glial cells: pro… (10.3389/fphar.2013.00088) | Abstract References ORCID License | 230.32 | 200 |
| 31 | The use of lipid-based nanocarriers for targeted pain therap… (10.3389/fphar.2013.00143) | Abstract References ORCID License | 230.10 | 199 |
| 32 | Diabetes and Alpha Lipoic Acid (10.3389/fphar.2011.00069) | Abstract References ORCID License | 229.00 | 194 |
| 33 | Traditional medicines and globalization: current and future… (10.3389/fphar.2013.00092) | Abstract References ORCID License | 228.78 | 193 |
| 34 | Systemic cancer therapy: achievements and challenges that li… (10.3389/fphar.2013.00057) | Abstract References ORCID License | 227.88 | 189 |
| 35 | Microglial Activation – Tuning and Pruning Adult Neurogenesi… (10.3389/fphar.2012.00041) | Abstract References ORCID License | 225.29 | 178 |
| 36 | A Gut Feeling about GABA: Focus on GABAB Receptors (10.3389/fphar.2010.00124) | Abstract References ORCID License | 223.80 | 172 |
| 37 | Fibroblasts in fibrosis: novel roles and mediators (10.3389/fphar.2014.00123) | Abstract ORCID License | 222.67 | 930 |
| 38 | Direct Antioxidant Properties of Bilirubin and Biliverdin. I… (10.3389/fphar.2012.00030) | Abstract References ORCID License | 222.27 | 166 |
| 39 | Extracellular Vesicles – Biomarkers and Effectors of the Cel… (10.3389/fphar.2013.00021) | Abstract References ORCID License | 219.31 | 155 |
| 40 | Eosinophilic Inflammation in Allergic Asthma (10.3389/fphar.2013.00046) | Abstract References ORCID License | 219.03 | 154 |
| 41 | Anti-cancer activities of pH- or heat-modified pectin (10.3389/fphar.2013.00128) | Abstract References ORCID License | 218.47 | 152 |
| 42 | Sirtuins and Disease: The Road Ahead (10.3389/fphar.2012.00004) | Abstract References ORCID License | 217.32 | 148 |
| 43 | The Effects of Psychostimulant Drugs on Blood Brain Barrier… (10.3389/fphar.2012.00121) | Abstract References ORCID License | 217.32 | 148 |
| 44 | Glutamate Neurocircuitry: Theoretical Underpinnings in Schiz… (10.3389/fphar.2012.00195) | Abstract References ORCID License | 217.03 | 147 |
| 45 | lazar: a modular predictive toxicology framework (10.3389/fphar.2013.00038) | Abstract References ORCID License | 216.14 | 144 |
| 46 | Therapeutic strategies for preventing skeletal muscle fibros… (10.3389/fphar.2015.00087) | Abstract References ORCID License | 215.23 | 141 |
| 47 | Glutathione: new roles in redox signaling for an old antioxi… (10.3389/fphar.2014.00196) | Abstract ORCID License | 215.19 | 739 |
| 48 | Calcium Signaling and Gliotransmission in Normal vs. Reactiv… (10.3389/fphar.2012.00139) | Abstract References ORCID License | 214.30 | 138 |
| 49 | NLRP3 inflammasome and its inhibitors: a review (10.3389/fphar.2015.00262) | Abstract ORCID License | 214.12 | 715 |
| 50 | Small Molecules, Inhibitors of DNA-PK, Targeting DNA Repair,… (10.3389/fphar.2013.00005) | Abstract References ORCID License | 212.71 | 133 |